UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Ametek
AME
|
+$778M |
| 2 |
Microsoft
MSFT
|
+$432M |
| 3 |
Amazon
AMZN
|
+$423M |
| 4 |
Apple
AAPL
|
+$190M |
| 5 |
Prologis
PLD
|
+$168M |
Top Sells
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$510M |
| 3 |
ConocoPhillips
COP
|
+$381M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Scholastic
SCHL
$687M
| $1.38M | ﹤0.01% |
35,000
-1,626
| -4% | -$64.2K |
|
1652
Brinker International
EAT
$7.07B
| $1.38M | ﹤0.01% |
43,192
+940
| +2% | +$30K |
|
1653
Ingles Markets
IMKTA
$1.32B
| $1.37M | ﹤0.01% |
14,245
| – | – |
|
1654
Expro
XPRO
$1.45B
| $1.37M | ﹤0.01% |
75,296
+12,454
| +20% | +$226K |
|
1655
Twist Bioscience
TWST
$1.55B
| $1.35M | ﹤0.01% |
56,895
+2,601
| +5% | +$61.9K |
|
1656
Worthington Enterprises
WOR
$3.26B
| $1.35M | ﹤0.01% |
44,183
-23,792
| -35% | -$729K |
|
1657
Embecta
EMBC
$895M
| $1.35M | ﹤0.01% |
53,355
-1,504
| -3% | -$38K |
|
1658
Celldex Therapeutics
CLDX
$1.67B
| $1.35M | ﹤0.01% |
30,242
| – | – |
|
1659
SiTime
SITM
$6.72B
| $1.34M | ﹤0.01% |
13,220
+1,023
| +8% | +$104K |
|
1660
Appian
APPN
$2.33B
| $1.34M | ﹤0.01% |
41,084
-1,197
| -3% | -$39K |
|
1661
Travere Therapeutics
TVTX
$2.23B
| $1.34M | ﹤0.01% |
63,578
+1,152
| +2% | +$24.2K |
|
1662
Seaboard Corp
SEB
$3.78B
| $1.34M | ﹤0.01% |
354
-3
| -0.8% | -$11.3K |
|
1663
Avidity Biosciences
RNA
$5.28B
| $1.34M | ﹤0.01% |
60,177
+36,455
| +154% | +$809K |
|
1664
Asana
ASAN
$3.26B
| $1.33M | ﹤0.01% |
96,628
+29,307
| +44% | +$404K |
|
1665
Laureate Education
LAUR
$4.28B
| $1.33M | ﹤0.01% |
138,143
-10,701
| -7% | -$103K |
|
1666
Oxford Industries
OXM
$770M
| $1.33M | ﹤0.01% |
14,222
-1,620
| -10% | -$151K |
|
1667
Telephone and Data Systems
TDS
$4.53B
| $1.32M | ﹤0.01% |
125,886
+22,039
| +21% | +$231K |
|
|
NXGN
1668
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.32M | ﹤0.01% |
70,210
+635
| +0.9% | +$11.9K |
|
|
CSW
1669
CSW Industrials, Inc.
CSW
$4.28B
| $1.32M | ﹤0.01% |
11,360
| – | – |
|
1670
ePlus
PLUS
$1.99B
| $1.31M | ﹤0.01% |
29,569
| – | – |
|
1671
Virtus Investment Partners
VRTS
$1.36B
| $1.3M | ﹤0.01% |
6,797
+505
| +8% | +$96.7K |
|
1672
Westamerica Bancorp
WABC
$1.26B
| $1.3M | ﹤0.01% |
22,034
| – | – |
|
1673
Clearfield
CLFD
$470M
| $1.3M | ﹤0.01% |
13,811
+770
| +6% | +$72.5K |
|
1674
Stock Yards Bancorp
SYBT
$2.28B
| $1.29M | ﹤0.01% |
19,896
+393
| +2% | +$25.5K |
|
1675
TriMas Corp
TRS
$1.59B
| $1.29M | ﹤0.01% |
46,564
-2,352
| -5% | -$65.2K |
|